quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 31, 2025

Trump 2.0, stocks soar again, gold hits records, AI boom rolls on — Yahoo Finance's 2025 year in review

View original at finance.yahoo.com
Trump 2.0, stocks soar again, gold hits records, AI boom rolls on — Yahoo Finance's 2025 year in review When the closing bell rings on Wall Street Wednesday afternoon, the S&P 500 (^GSPC) will clinch its third straight year of double-digit gains and end the year near a record high…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Criticized One Big Beautiful Bill as a 'disgusting abomination'

    80% confidence

  • Authorized 90 day pause and substantially lowered reciprocal tariff to 10%, while raising China tariffs to 125%

    80% confidence

  • This is a critical time for ChatGPT after Gemini 3 release

    80% confidence

  • Stock and bond market was 'yippy' and people were jumping a bit out of line

    80% confidence

  • AI-related investment will be notably larger than $71 billion planned for 2025

    80% confidence

  • Economic outlook and labor market changes may warrant shift in Fed's interest rate stance

    80% confidence

  • Tesla's autonomous future will focus far less on selling cars

    80% confidence

  • Called market rally the 'biggest day in financial history'

    80% confidence

  • DeepSeek AI model can rival OpenAI models for a fraction of the cost

    80% confidence

  • Lisa Cook fired for alleged mortgage fraud related to buying two properties

    80% confidence

  • Recommended to Berkshire board that Greg Abel be designated CEO with start date of Jan 1, 2026

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Trump 2.0, stocks soar again, gold hits records, AI boom rolls on — Yahoo Finance's 2025 year in review — Source | Via News | pt.VIA.NEWS